Trials / Completed
CompletedNCT00372372
The Efficacy of Risedronate in Prevention of Bone Loss in Patients Receiving High Dose Corticosteroid Treatment
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (planned)
- Sponsor
- Tuen Mun Hospital · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The efficacy of risedronate in prevention of bone loss in patients receiving high dose corticosteroid treatment
Detailed description
We compare the effect of risedronate with placebo in bone mineral density changes in patients receiving high dose corticosteroids for their underlying diseases
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | risedronate |
Timeline
- Start date
- 2004-01-01
- Completion
- 2007-04-01
- First posted
- 2006-09-06
- Last updated
- 2007-09-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00372372. Inclusion in this directory is not an endorsement.